Modifi Biosciences, Inc., a leader in the development of direct DNA modification enabled cancer therapeutics, has been ...

In a report released today, Charlie CY Yang from Bank of America Securities maintained a Buy rating on Merck & Company (MRK – ...

Merck (MRK) announced that the European Commission (EC) has approved two new indications for Keytruda, Merck’s anti-PD-1 therapy, in ...

MSD has acquired US cancer therapeutics developer Modifi Biosciences, a Yale University spinout, enhancing its portfolio with ...

Current health news covers Roche's opposition to Catalent's takeover, cost analysis of weight-loss drugs like Wegovy, U.S.

Merck’s acquisition of Modifi Biosciences will give it access to preclinical cancer drug candidates that target DNA repair ...

The acquisition strengthens Merck's oncology portfolio as the company looks to off the expiration of the patent for ...

Modifi Biosciences announced that it has been acquired by global pharmaceutical giant Merck, with a $30 million down payment.

Advisers to the Centers for Disease Control and Prevention on Wednesday recommended expanding the use of vaccines to adults ...